Evolution of Analytical Procedure Validation Concepts: Part I

Publication
Article
BioPharm InternationalBioPharm International Quality and Regulatory Sourcebook 2023
Volume 2023 eBook
Issue 1
Pages: 14–21

This article provides an overview of validation concept principles evolution to a life cycle risk-based approach with focus on compendial perspectives.

Hand holding wooden block with tick mark, satisfaction survey ,mental health assessment, checklist business, project tracking, goal tracker, task completion concept. Image Credit: ©sewcream - sewcream-stock.adobe.com

sewcream - Stock.adobe.com

In recent years, regulatory agencies have placed an increased emphasis on pharmaceutical process understanding through adoption of quality-by-design (QbD) principles by launching a series of initiatives to encourage the pharmaceutical industry to adopt QbD in the manufacturing process. A key component of this transformation is the evolution of validation concepts to a life cycle risk-based approach driven by analytical quality by design (AQbD) principles. Different pharmacopoeias have been developing compendial approaches to support the implementation of analytical procedure life cycle (APLC) risk-based approach. Additionally, the International Council for Harmonisation (ICH) released in March 2022 two draft guidelines for public consultation which outline QbD principles: ICH Q14 (procedure development) (1), and the ICH Q2(R2) (procedure validation) (2). In a series of two articles, the authors will provide an overview of the validation concept principles evolution with a focus on compendial perspectives (Part I) and draw a parallel between ICH Q14 and Q2(R2) and United States Pharmacopeia (USP) General Chapter <1220> and the ISO/IEC 17025:2017 (Part II).

Read the article in BioPharm International’s Quality and Regulatory Sourcebook March 2023

About the authors

Amanda Guiraldelli is scientific affairs manager at the United States Pharmacopeia.
Jane Weitzel is an independent consultant and chair of the US Pharmacopeia Expert Committee on Measurement and Data Quality.

Article details

BioPharm International
eBook: Quality and Regulatory Sourcebook 2023
March 2023
Pages: 14–21

Citation

When referring to this article, please cite it as Guiraldelli, A. and Weitzel, J. Evolution of Analytical Procedure Validation Concepts: Part I. BioPharm International Quality and Regulatory Sourcebook 2023. March 2023.

Articles in this issue
Standard quality control. Certification. Business, technology, internet and networking concept | Image Credit: © PHOTON_PHOTO - STOCK.ADOBE.COM
Mitigating Human Error and Supporting Compliance with Smart Technology
Murrstock - Stock.adobe.com
Phase-appropriate Analytical Methodology
Business process management, Businessman plan a project with wooden cubes with icon business strategy on blue background. copy space. Image Credit: ©Worawut -Worawut - Stock.adobe.com
Evolution of Analytical Procedure Validation Concepts: Part II
Pharmacovigilance Automation
Pharmacovigilance Automation
Hand holding wooden block with tick mark, satisfaction survey ,mental health assessment, checklist business, project tracking, goal tracker, task completion concept. Image Credit: ©sewcream - sewcream-stock.adobe.com
Evolution of Analytical Procedure Validation Concepts: Part I
relif - Stock.adobe.com
Points to Consider for Knowledge Management Acceleration
Recent Videos
Christa Myers, CRB Group; Nadiyra Walker Speight, Fujifilm Diosynth Biotechnologies
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Approves PTC Therapeutics’ Gene Therapy for AADC Deficiency

Feliza Mirasol
November 18th 2024
Article

The approval of eladocagene exuparvovec-tneq (Kebilidi) marks the first FDA approval for a gene therapy to treat AADC deficiency.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Lecanemab Gets Nod from CHMP for Use in Early Alzheimer’s Disease

Felicity Thomas
November 15th 2024
Article

Eisai Europe and Biogen have received a positive opinion for the monoclonal antibody therapy to be used as a treatment of adult patients with early Alzheimer’s disease.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Budget Announcement Prompts UK Medicines Manufacturing Skills Centre to Emphasize Need for Skills Development

Susan Haigney
November 11th 2024
Article

Chancellor of the Exchequer, Rachel Reeves, has announced a £520 million (US$675 million) investment for manufacturing capacity in the United Kingdom, prompting academic and industry leaders to point out that funds should be used to train personnel.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

RSV Vaccine Approved for Adults 18–59

Susan Haigney
October 23rd 2024
Article

Pfizer’s bivalent RSV prefusion F vaccine has been approved by FDA to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at increased risk.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Recommends Several Medicines in October

Susan Haigney
October 18th 2024
Article

The agency’s CHMP recommended drugs to treatments for hemophilia, two biosimilars for psoriasis, and two flu vaccines at their October meeting.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA and HMA Publish Network Strategy for Public Consultation

Susan Haigney
October 11th 2024
Article

The draft joint network strategy for the EU until 2028 will be open for public consultation until Nov. 30, 2024.

© 2024 MJH Life Sciences

All rights reserved.